documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
23 rows where docket_id = "FDA-1993-P-0037" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1993-P-0037-0031 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Petition Denial from FDA CDER to Wiley, Rein & Fielding | Other | Denial | 2014-03-07T05:00:00Z | 2014 | 3 | 2014-03-07T05:00:00Z | 2025-01-28T16:15:12Z | 0 | 0 | 09000064804fbef6 | ||
| FDA-1993-P-0037-0030 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab A 1- 2 - Mylan Pharmaceuticals, Inc. - [Wiley, Rein & Fielding - Petition for Stay] | Other | PSA-Petition for Stay | 2010-05-28T04:00:00Z | 2010 | 5 | 2010-05-28T04:00:00Z | 2010-10-29T01:01:31Z | 0 | 0 | 09000064804fbec5 | ||
| FDA-1993-P-0037-0024 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab D - Letter from Wiley, Rein & Fielding to FDA DMB re: Petition for Stay | Other | Background Material | 2010-05-27T04:00:00Z | 2010 | 5 | 2010-05-27T04:00:00Z | 2025-09-19T20:05:53Z | 0 | 0 | 09000064804fbea5 | ||
| FDA-1993-P-0037-0027 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Points to Consider re: Petition for Stay | Other | Background Material | 2010-05-27T04:00:00Z | 2010 | 5 | 2010-05-27T04:00:00Z | 2025-09-19T20:23:46Z | 0 | 0 | 09000064804fbeaf | ||
| FDA-1993-P-0037-0026 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab F - Letter from Wiley, Rein & Fielding to FDA DMB re: Petition for Stay | Other | Background Material | 2010-05-27T04:00:00Z | 2010 | 5 | 2010-05-27T04:00:00Z | 2025-09-19T20:20:53Z | 0 | 0 | 09000064804fbeac | ||
| FDA-1993-P-0037-0025 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab E - Letter from Wiley, Rein & Fielding to FDA DMB re: Petition for Stay | Other | Background Material | 2010-05-27T04:00:00Z | 2010 | 5 | 2010-05-27T04:00:00Z | 2025-09-19T20:11:52Z | 0 | 0 | 09000064804fbea8 | ||
| FDA-1993-P-0037-0029 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Exhibit 5 - Biopharmaceutical Considerations re: Petition for Stay | Other | Background Material | 2010-05-27T04:00:00Z | 2010 | 5 | 2010-05-27T04:00:00Z | 2025-09-19T20:46:23Z | 0 | 0 | 09000064804fbeba | ||
| FDA-1993-P-0037-0028 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Petition for Withdrawal or Stay from Wiley, Rein & Fielding on behalf of Pfizer Inc. | Other | Petition(s) | 2010-05-27T04:00:00Z | 2010 | 5 | 2010-05-27T04:00:00Z | 2025-09-19T20:25:34Z | 0 | 0 | 09000064804fbeb2 | ||
| FDA-1993-P-0037-0023 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab 26 - Center for Drug Evaluation and Research, FDA, Tr. for Jan. 11-12, 1994 Meeting of the Generic Drug Advisory Committee | Other | Supplement (SUP) | 2010-05-21T04:00:00Z | 2010 | 5 | 2010-05-21T04:00:00Z | 2025-09-19T20:01:24Z | 0 | 0 | 09000064804fbe44 | ||
| FDA-1993-P-0037-0021 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab 26 - Center for Drug Evaluation and Research, FDA, Tr. for Jan. 11-12, 1994 Meeting of the Generic Drug Advisory Committee | Other | Supplement (SUP) | 2010-05-21T04:00:00Z | 2010 | 5 | 2010-05-21T04:00:00Z | 2025-09-19T19:54:49Z | 0 | 0 | 09000064804fbe3a | ||
| FDA-1993-P-0037-0019 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab 25 - Center for Drug Evaluation and Research, FDA, Tr. for Jan. 11-12, 1994 Meeting of the Generic Drug Advisory Committee | Other | Supplement (SUP) | 2010-05-21T04:00:00Z | 2010 | 5 | 2010-05-21T04:00:00Z | 2025-09-19T19:51:44Z | 0 | 0 | 09000064804fbe30 | ||
| FDA-1993-P-0037-0022 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab 26 - Center for Drug Evaluation and Research, FDA, Tr. for Jan. 11-12, 1994 Meeting of the Generic Drug Advisory Committee | Other | Supplement (SUP) | 2010-05-21T04:00:00Z | 2010 | 5 | 2010-05-21T04:00:00Z | 2025-09-19T20:00:12Z | 0 | 0 | 09000064804fbe3e | ||
| FDA-1993-P-0037-0020 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab 25 - Center for Drug Evaluation and Research, FDA, Tr. for Jan. 11-12, 1994 Meeting of the Generic Drug Advisory Committee | Other | Supplement (SUP) | 2010-05-21T04:00:00Z | 2010 | 5 | 2010-05-21T04:00:00Z | 2025-09-19T19:53:01Z | 0 | 0 | 09000064804fbe35 | ||
| FDA-1993-P-0037-0017 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab 24 - Center for Drug Evaluation and Research, FDA, Summary Minutes for Jan. 11-12, 1994 Meeting of the Generic Drug Advisory Committee (June 26, 1994) | Other | Supplement (SUP) | 2010-04-29T04:00:00Z | 2010 | 4 | 2010-04-29T04:00:00Z | 2025-09-19T19:48:50Z | 0 | 0 | 09000064804fbe27 | ||
| FDA-1993-P-0037-0016 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Supplement 2 re: Pfizer Inc. | Other | Supplement (SUP) | 2010-04-29T04:00:00Z | 2010 | 4 | 2010-04-29T04:00:00Z | 2025-09-19T19:42:51Z | 0 | 0 | 09000064804fbe22 | ||
| FDA-1993-P-0037-0018 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Tab 25 - Center for Drug Evaluation and Research, FDA, Tr. for Jan. 11-12, 1994 Meeting of the Generic Drug Advisory Committee | Other | Supplement (SUP) | 2010-04-29T04:00:00Z | 2010 | 4 | 2010-04-29T04:00:00Z | 2025-09-19T19:50:41Z | 0 | 0 | 09000064804fbe2a | ||
| FDA-1993-P-0037-0005 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Supplement 1 re: Pfizer Inc. | Other | Supplement (SUP) | 2010-04-28T04:00:00Z | 2010 | 4 | 2010-04-28T04:00:00Z | 2025-09-19T19:35:26Z | 0 | 0 | 09000064804fbdcc | ||
| FDA-1993-P-0037-0015 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Supplement 2 re: Pfizer Inc. | Other | Supplement (SUP) | 2010-04-28T04:00:00Z | 2010 | 4 | 2010-04-28T04:00:00Z | 2025-09-19T19:40:50Z | 0 | 0 | 09000064804fbe48 | ||
| FDA-1993-P-0037-0013 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Supplement 3 re: Pfizer Inc. | Other | Supplement (SUP) | 2010-04-28T04:00:00Z | 2010 | 4 | 2010-04-28T04:00:00Z | 2025-09-19T19:33:17Z | 0 | 0 | 09000064804fbea2 | ||
| FDA-1993-P-0037-0008 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Letter from FDA CDER to Wiley, Rein & Fielding | Other | Letter(s) | 2010-04-28T04:00:00Z | 2010 | 4 | 2010-04-28T04:00:00Z | 2025-01-28T15:16:42Z | 0 | 0 | 09000064804fbddc | ||
| FDA-1993-P-0037-0003 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Citizen Petition from Wiley, Rein & Fielding on behalf of Pfizer Inc. | Other | Citizen Petition | 2010-04-28T04:00:00Z | 2010 | 4 | 2010-04-28T04:00:00Z | 2025-01-28T14:56:02Z | 0 | 0 | 09000064804fbda2 | ||
| FDA-1993-P-0037-0004 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Exhibit 3 -Approved Drug Products with Therapeutic Equivalence Evaluations | Other | Exhibit(s) | 2010-04-28T04:00:00Z | 2010 | 4 | 2010-04-28T04:00:00Z | 2025-09-19T19:28:51Z | 0 | 0 | 09000064804fbdc0 | ||
| FDA-1993-P-0037-0002 | FDA | Modify ANDA Suitability Petition Processing Practices -CLOSED FDA-1993-P-0037 | Acknowledgement Letter from FDA DMB to Wiley, Rein & Fielding | Other | Acknowledgement Letter/Receipt | 1997-07-02T04:00:00Z | 1997 | 7 | 2025-01-28T14:48:40Z | 0 | 0 | 09000064804fbefb |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);